# UCB Pharma S.A., Brabant Wallon, Belgium – FDA Inspections

Source: https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

> Inspection records and compliance data for UCB Pharma S.A. in Brabant Wallon. 9 FDA inspections on record, 3 Form 483s, last inspected June 04, 2026.

---

## Details

- Name: UCB Pharma S.A.
- FEI Number: 3003909356
- Facility Type: Drug Product
- Business Operations: API MANUFACTURE
- Address Line 1: Chemin Du Foriest
- Address Line 2: Braine-L'Alleud
- City: Brabant Wallon
- Country Name: Belgium
- Address: Chemin Du Foriest Braine-L'Alleud, Brabant Wallon, Belgium
- Country: Belgium

## Related Documents

- [483 - UCB Pharma S.A. - Unknown Date](https://www.keypedia.com/records/483/ucb-pharma-sa/7634bf8a-098c-4f65-869f-8b8dc49bf228) — source: FDA, date: Invalid Date
- [FDA Inspection 1323186 - UCB Pharma S.A. - 2026-06-04](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/fb6ef372-1365-40fa-85fa-7cf1948da79c) — source: FDA, date: June 4, 2026
- FDA Inspection 1247808 - UCB Pharma S.A. - 2024-02-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2024
- [483 - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/483/ucb-pharma-sa/faf15e0c-4ee4-4868-84c5-48cd719f4855) — source: FDA, date: April 21, 2023
- [EIR - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/eir/ucb-pharma-sa/0a4d5150-1f3d-4902-a9e3-98e6c80b367f) — source: FDA, date: April 21, 2023
- [FDA Inspection 1208307 - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/9be817f5-ce00-46cd-81a9-df3f6367f9ac) — source: FDA, date: April 21, 2023
- [483 - UCB Pharma S.A. - 2022-02-04](https://www.keypedia.com/records/483/ucb-pharma-sa/6036226d-2920-43af-9bd3-61847498eee7) — source: FDA, date: February 4, 2022
- [EIR - UCB Pharma S.A. - 2022-02-04](https://www.keypedia.com/records/eir/ucb-pharma-sa/c0412e1a-bd81-4e61-8d2c-6bc873ddb1ac) — source: FDA, date: February 4, 2022
- FDA Inspection 1170317 - UCB Pharma S.A. - 2021-11-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 25, 2021
- [FDA Inspection 1013309 - UCB Pharma S.A. - 2017-01-27](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/b869769c-b1b8-4e08-b406-591c9e291b9f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 27, 2017
- [FDA Inspection 946302 - UCB Pharma S.A. - 2015-09-11](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/4a28d1df-64ef-4aa7-b8ac-3606f8d6b0de) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2015
- FDA Inspection 908458 - UCB Pharma S.A. - 2014-12-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2014
- FDA Inspection 822144 - UCB Pharma S.A. - 2013-02-01 — classification: No Action Indicated (NAI), source: FDA, date: February 1, 2013
- FDA Inspection 744056 - UCB Pharma S.A. - 2011-07-01 — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2011

## Related Companies

- [Ava Inc](https://www.keypedia.com/companies/ava-inc/2b241090-1e53-4f25-8e52-c8105395fb0b)
- [Bajaj Medical, LLC](https://www.keypedia.com/companies/bajaj-medical-llc/3aea5c6c-9e94-429d-82a0-594d8f8c666e)
- [AndersonBrecon Inc.](https://www.keypedia.com/companies/andersonbrecon-inc/799f84ea-9114-456a-83f1-7edcd7eb4d2e)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [Kindeva Drug Delivery Limited](https://www.keypedia.com/companies/kindeva-drug-delivery-limited/901e9a7f-5182-43e1-9980-391fca7364b7)
- [Pharma Nobis LLC](https://www.keypedia.com/companies/pharma-nobis-llc/65e636d3-cd04-456d-b82a-a681bb7bdb9e)
- [Chartwell Pharmaceuticals Carmel LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-carmel-llc/7d10681a-1557-4f23-bde4-a9fad718e27f)
- [Everest Life Sciences LLC](https://www.keypedia.com/companies/everest-life-sciences-llc/3f0de21d-b48b-4f8a-a8a2-3b6e376528f4)
- [Chartwell Pharmaceuticals LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-llc/4a8c4844-be98-403a-8cb5-5fc90d592679)
- [Eurofins Advantar Laboratories, Inc](https://www.keypedia.com/companies/eurofins-advantar-laboratories-inc/fe88e38f-0ce0-4e6e-a1bb-ed73634ac024)

## Related Officers

- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)
- [ Investigator, Consumer Safety Officer](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)
